Two Sigma Investments’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-470,344
Closed -$7.9M 3123
2022
Q1
$7.9M Sell
470,344
-198,009
-30% -$3.46M 0.02% 700
2021
Q4
$13.3M Buy
668,353
+280,776
+72% +$5.29M 0.03% 650
2021
Q3
$7.03M Buy
387,577
+352,503
+1,005% +$8.08M 0.02% 978
2021
Q2
$947K Buy
+35,074
New +$981K ﹤0.01% 2515
2021
Q1
Sell
-23,539
Closed -$677K 4371
2020
Q4
$677K Sell
23,539
-96,815
-80% -$2.61M ﹤0.01% 2290
2020
Q3
$2.94M Buy
120,354
+2,372
+2% +$51.2K 0.01% 1083
2020
Q2
$2.11M Sell
117,982
-385,268
-77% -$5.06M 0.01% 1070
2020
Q1
$4.1M Sell
503,250
-359,237
-42% -$4.1M 0.03% 589
2019
Q4
$11.4M Buy
862,487
+626,482
+265% +$7.59M 0.03% 566
2019
Q3
$2.81M Buy
+236,005
New +$4.37M 0.01% 1175

Other funds holding CVET

Two Sigma Investments's CVET Position: Q2 2022 in Review

Two Sigma Investments sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2022, closing a stake of 470,344 shares — an estimated $7.9M sold.

Two Sigma Investments first reported a position in CVET in Q3 2019 and held it in 10 quarters. The position peaked at $13.3M in Q4 2021. 266 funds tracked by Wall St. Rank hold CVET as of Q2 2022.

  • Two Sigma Investments reported no remaining Covetrus, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Investments sold 470,344 Covetrus, Inc. Common Stock shares in Q2 2022, an estimated $7.9M.
  • Two Sigma Investments first reported a position in Covetrus, Inc. Common Stock in Q3 2019 and held it in 10 quarters.
  • Two Sigma Investments's Covetrus, Inc. Common Stock position peaked at $13.3M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2022.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.